You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
华润医药(03320.HK)旗下华润三九治疗肺炎药品获内地颁注册证书
阿思达克 11-06 15:26
华润医药(03320.HK)旗下子公司华润三九(000999.SZ)获得国家药品监督管理局颁发的注射用头孢比罗酯钠(商品名为「赛比普」)药品注册证书。

注射用头孢比罗酯钠主要用於治疗医院获得性肺炎(HAP)及社区获得性肺炎(CAP)等成人的感染。其中头孢比罗酯是一种头孢菌素抗生素,可静脉内给药,对多种革兰氏阳性和革兰氏阴性细菌具有杀菌活性。其中包括对甲氧西林敏感和耐药的金黄色葡萄球菌和敏感的假单胞菌。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account